Company Update: Agilent Technologies Inc (NYSE:A) – TRADE NEWS: Agilent Technologies Microarray Scanner Approved for In Vitro Diagnostics in China

[Business Wire] – Agilent Technologies Inc. today announced that the China Food and Drug Administration has approved the company’s SureScan Dx microarray scanner as a medical device for in Read more on this. . . . → Read More: Company Update: Agilent Technologies Inc (NYSE:A) – TRADE NEWS: Agilent Technologies Microarray Scanner Approved for In Vitro Diagnostics in China Similar Articles: Market Update (NYSE:A): TRADE NEWS: Agilent Technologies Introduces Microarray for Rapid Screening of Aneuploidy in Single Cells from Embryos Market Update (NYSE:A): TRADE NEWS: Agilent Technologies Introduces Modular Real-Time PCR System with Precision Optics and Dependable Thermal Uniformity Market Update: Agilent Technologies Inc (NYSE:A) – TRADE NEWS: Agilent Technologies and Shimadzu Enable Control of Each Other’s GC Instruments in Respective Chromatographic Data Systems